Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel histamine H3 receptor antagonists for the treatment of AD presented by Wyeth

April 29, 2009

Long-lasting efficacy seen with botulinum toxin type B in PD patients with sialorrhea

April 29, 2009

Once-daily antiepileptic Zebinix approved in the European Union

April 28, 2009

Janssen receives Japanese approval to market Risperdal Consta for schizophrenia

April 28, 2009

Choongwae patents GSK-3beta inhibitors for the treatment of Alzheimer's disease

April 28, 2009

Nycomed's Instanyl receives positive CHMP opinion for cancer pain

April 27, 2009

AcelRx initiates phase II cancer breakthrough pain program

April 27, 2009

Novel vanilloid receptor ligands for the treatment of pain disclosed by Amgen

April 27, 2009

Addrenex and Sciele report results for second phase III Clonicel study in ADHD

April 24, 2009

Molecular Sensing and VIB enter agreement in Alzheimer's disease research

April 24, 2009

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...